The Poliomyelitis vaccine, commonly known as the polio vaccine, is a critical tool in preventing poliomyelitis, a highly contagious viral disease caused by the poliovirus. The vaccine primarily comes in two forms: the inactivated poliovirus vaccine (IPV) and the oral poliovirus vaccine (OPV). IPV is an injectable vaccine that contains killed poliovirus strains, providing immunity without causing the disease. OPV, administered orally, contains weakened but live poliovirus strains, promoting both individual and community immunity. The Global Polio Eradication Initiative, launched by the World Health Organization (WHO), aims to eradicate polio globally through mass vaccination campaigns. Significant progress has been made, reducing polio cases dramatically. While IPV is widely used in many developed countries, OPV is crucial for immunization campaigns in endemic regions due to its ease of administration. Eradicating polio remains a global health priority, and ongoing research focuses on refining vaccination strategies and addressing challenges in reaching vulnerable populations.
Submit your abstract Today
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : Prophylactic and Molecular Approaches for Mitigating Human Influenza A Viruses: i. Evaluating influenza Vaccine Effectiveness in the Older population ii. Down-regulation of influenza virus genes with novel siRNA-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Development of a Novel Multi-component Vaccine to Address the Burden of Otitis Media in High-Risk Populations
Ayesha Zahid, Griffith University, Australia
Title : Targeting resistance: New 4-substituted pyrazolidine and isoxazolidine as antibiotics with interesting antimicrobial activities
Yousfi Tarek, Nationale Research for Biotechnology Research Center, Algeria
Title : Racial disparities in pediatric pneumonia in Brazil: The role of structural racism forging inequalities in acess to vaccines
Livia Daflon Silva, Federal University of State of Rio de Janeiro, Brazil
Title : Immunosuppression in COVID-19 Patients and Emerging Fungal Infections: Vaccines, Diagnosis and Strategies to Treat Comorbidities
K R Aneja, Kurukshetra University, India
Title : Immunogenicity and Cryo-EM structure of native-like HIV-1 Clade-C envelope trimers derived from a pediatric elite-neutralizer
Swarandeep Singh, All India Institute of Medical Sciences, India
Title : Why is the vaccine life-threatening if people get a fever after a COVID-19 vaccination
Yacob Mathai, Marma Health Centre, India
Title : Barriers to polio eradication in South Asia: A systematic review
Awranoos Ahadi, Bolan Medical College, Pakistan